SCHEMBL23732134

SCHEMBL23732134

C[C@@H]1CC1Sc1ccccc1Cl

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.35
TSHR P16473 1/20 0.35
TAS1R3 Q7RTX0 2/20 0.33
TAS1R1 Q7RTX1 2/20 0.33
HAO1 Q9UJM8 1/20 0.33
LDHA P00338 8/20 0.32
LDHB P07195 4/20 0.32
TAS1R2 Q8TE23 1/20 0.32
RHEB Q15382 1/20 0.32
FBP1 P09467 1/20 0.32
TP53 P04637 1/20 0.32
RECQL P46063 1/20 0.32
HPGD P15428 1/20 0.31
KDM4E B2RXH2 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21340222 1.00 LMNA (0.35) LMNATSHRTAS1R3TAS1R1HAO1
SCHEMBL19904656 0.76 TAS1R3 (0.35) TAS1R3TAS1R1LDHALDHBTAS1R2
SCHEMBL19904654 0.76 CA1 (0.34) TSHRKDM4EL3MBTL1
SCHEMBL1139693 0.73 DPP4 (0.39) LMNATSHRHAO1LDHALDHB
SCHEMBL2657669 0.72 LMNA (0.39) LMNATSHRHAO1LDHALDHB
SCHEMBL9264331 0.71 RAB9A (0.46) TSHRTAS1R3TAS1R1LDHALDHB
SCHEMBL9264328 0.71 RAB9A (0.46) TSHRTAS1R3TAS1R1LDHALDHB
SCHEMBL9264336 0.71 RAB9A (0.46) TSHRTAS1R3TAS1R1LDHALDHB
SCHEMBL1856547 0.69 CA12 (0.37) LMNATSHRTAS1R3TAS1R1HAO1
SCHEMBL5636187 0.68 SLC6A2 (0.41) LMNATSHRTP53NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3912977-A1 GLUCOSYLCERAMIDE SYNTHASE INHIBITORS FOR THE TREATMENT OF DISEASES BioMarin Pharmaceutical Inc. (US) 2021-11-24 EP disclosed
EP-3046920-B1 GLUCOSYLCERAMIDE SYNTHASE INHIBITORS FOR THE TREATMENT OF DISEASES BIOMARIN PHARM INC (US) 2021-08-04 EP disclosed